Dividing her days between treating malaria in Kenya’s coastal regions and administering the latest malaria vaccine prototype, Dr. Patricia Njuguna has high hopes for preventing a disease that annually claims more...
Malaria mortality rates have fallen by more than 25% globally since 2000, and by 33% in the WHO African Region, according to the World Malaria Report 2011, issued by the World Health Organization.
A new analysis of progress in the global fight against malaria has found a four-fold increase in annual funding for malaria research and development (R&D) in just 16 years
A new study uncovers a powerful strategy for eliciting an immune response that can combat the parasite during multiple stages of its complex life cycle
The RTS,S Malaria vaccine, developed by pharmaceutical company GlaxoSmithKline (GSK) and PATH Malaria Vaccine Initiative (MVI), began its third clinical trial in Africa today.